Clinical Trial Update: The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial [Phase 4]

View source ↗

Summary

Phase 4 trial comparing REBIF (interferon beta-1a) with Glatiramer Acetate in relapsing multiple sclerosis. Results were posted in 2014 and included pharmacogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Rebif (interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Relapsing Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2014-03-10